tiprankstipranks
Trending News
More News >

Grand Pharmaceutical Clarifies Bye-Laws Document Headline Error

Story Highlights
Grand Pharmaceutical Clarifies Bye-Laws Document Headline Error

Confident Investing Starts Here:

An announcement from Grand Pharmaceutical Group Limited ( (HK:0512) ) is now available.

Grand Pharmaceutical Group Limited issued a clarification regarding an operational mistake in the headline of its Bye-Laws document. The headline was incorrectly labeled as ‘Documents on Display’ instead of ‘Constitutional Documents’. The company has corrected this error by re-uploading the document with the correct headline, ensuring that the content of the Bye-Laws remains unchanged.

More about Grand Pharmaceutical Group Limited

Grand Pharmaceutical Group Limited is a company incorporated in Bermuda, operating within the pharmaceutical industry. It focuses on the development and distribution of pharmaceutical products, with a market presence highlighted by its listing on the Hong Kong Stock Exchange.

YTD Price Performance: 27.29%

Average Trading Volume: 5,721,817

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$21.44B

For detailed information about 0512 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App